Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Strategic Alliance

24 Mar 2015 07:00

RNS Number : 2427I
Tekcapital plc
24 March 2015
 

24 March 2015

 

Tekcapital Plc

 

("Tekcapital", "the Company" or "the Group")

 

Tekcapital Announces a Strategic Alliance with 2Market Information, Inc.

 

 

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, is pleased to announce it has entered into a reseller alliance with 2Market Information, Inc., to market InventionEvaluator more widely to universities and companies engaged in technology commercialization.

 

InventionEvaluator®, a division of Tekcapital, provides in-depth analytical reports that assess the commercial potential of new technologies and intellectual property, thereby enabling clients to make more informed decisions regarding investments in new technologies. As part of the Alliance, 2Market Information, Inc. will make the InventionEvaluator reports available to its customers and network members worldwide.

 

2Market Information, Inc. is the world's leading provider of resources for technology transfer professionals. 2Market Information, Inc. owns and operates Tech Transfer Central, the home to leading publications, including Tech Transfer eNews, Technology Transfer Tactics and Tech Transfer University Reporter. Readership includes more than 150,000 decision makers in universities, labs, research facilities, law firms, investment and consulting firms, tech incubators, government agencies, corporations and other entities that have a stake in tech transfer or research commercialization. (http://techtransfercentral.com/).

 

Commenting on the announcement, Dr. Clifford M. Gross, Executive Chairman of Tekcapital plc said:

 

"The acquisition of InventionEvaluator has expanded our service offering and client base. To further expand its market penetration into universities and companies engaged in technology transfer we are very excited to have entered into a strategic alliance with 2Market Information, Inc. We believe their large network of individuals focused on technology commercialization is a perfect fit with InventionEvaluator reports, which provide guidance on the marketability of newly developed technologies."

Commenting on the announcement, David Schwartz, CEO and Publisher of 2Market Information Inc. said:

"We are very enthusiastic to be able to provide the InventionEvaluator service to our clients worldwide. We believe that InventionEvaluator's comprehensive and cost-effective reports, which assess the marketability of new technologies, should prove valuable to our customers."

 

For further information please contact:

 

Tekcapital Plc

+1 305 200 3450 Ext 305

Clifford M. Gross, Ph.D., Executive Chairman

cgross@tekcapital.com

 

 

2Market Information Inc.

+1 404-626-8191

David Schwartz, CEO and Publisher

dschwartz@techtransfercentral.com

 

 

Northland Capital Partners Limited (NOMAD & Broker)

+44 (0) 20 7382 1100

William Vandyk (Corporate Finance)

info@northlandcp.co.uk

John Howes

 

 

 

Optiva Securities Limited (Co-Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

 

 

FTI Consulting, LLP

+44 (0) 20 3727 1000

Chris Lane / Emma Appleton / Roger Newby

tekcapital@fticonsulting.com

 

  

About Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

About - 2Market Information Inc.

 

2Market Information, Inc. is the world's leading provider of resources in technology transfer. 2Market Information, Inc., owns and operates Tech Transfer Central, the home to leading publications, including: Tech Transfer eNews, Technology Transfer Tactics and Tech Transfer University Reporter. Readership includes more than 150,000 decision makers in universities, labs, research facilities, law firms, investment and consulting firms, tech incubators, government agencies, corporations and other entities that have a stake in tech transfer or research commercialization. For more information, please visit http://techtransfercentral.com/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPKNDDFBKDQNB
Date   Source Headline
27th May 20267:00 amRNSResults for Year Ended 31 December 2025
22nd May 20267:00 amRNSTekcapital takes stake in geothermal AI firm
21st May 20267:00 amRNSNew Orders
28th Apr 20267:00 amRNSStrategic Resale Alliance with Cardinal IP
18th Feb 20267:00 amRNSNotification of Major Holdings
10th Feb 20267:00 amRNSConditional Placing of £1.5 million
15th Jan 20267:00 amRNSCorporate Update
7th Jan 20267:00 amRNS-RPorfolio Company Update - Innovative Eyewear Inc
12th Dec 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear Inc
1st Dec 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
19th Nov 20257:00 amRNSPortfolio Company Update - Guident Corp
13th Nov 20257:00 amRNSInnovative Eyewear Q3 Unaudited Financial Results
13th Nov 20257:00 amRNSTrading Statement
10th Nov 20257:00 amRNS-RStrategic Alliance signed with Nexscient Inc
4th Nov 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
17th Oct 20254:15 pmRNSNotification of Major Holdings
13th Oct 20251:44 pmRNSPlacing of £0.37 Million
10th Oct 20257:00 amRNSNew Product Launch – Invention Validator
8th Oct 202510:53 amRNSReplacement - Unaudited Half-Yearly Report
7th Oct 20257:00 amRNS-RPortfolio Company Update Innovative Eyewear
6th Oct 20257:00 amRNSReplacement RNS: Half-year Report
30th Sep 20257:02 amRNSCommercial Strategy Update & New Products
30th Sep 20257:00 amRNSHalf-year Report
25th Sep 20257:00 amRNS-RPortfolio Company Update -Guident
24th Sep 20257:00 amRNSUnaudited Half Yearly Report
18th Sep 20257:00 amRNSPortfolio Company Update -Guident Proposed US IPO
10th Sep 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
29th Aug 20257:00 amRNS-RPortfolio Company Update Guident Corp
19th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
15th Aug 20257:00 amRNS-RPortfolio Company Update Innovative Eyewear Q2
13th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
6th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
25th Jul 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNS-RPortfolio Company Update - Guident Corp
21st Jul 20257:00 amRNS-RPortfolio Company Update- Innovative Eyewear
27th Jun 202512:39 pmRNSResult of AGM
19th Jun 20251:06 pmRNSNotification of Major Holdings
19th Jun 202511:07 amRNSHolding(s) in Company - Replacement
19th Jun 20257:00 amRNS-RPortfolio Company Update - Guident Corp
10th Jun 20257:00 amRNSContract Win
2nd Jun 20257:02 amRNSNotice of AGM
2nd Jun 20257:00 amRNSFinal Results Year Ended 31 December Notice of AGM
2nd Jun 20257:00 amRNSFundraising of £1.25 Million
29th May 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear Inc
23rd May 20257:00 amRNSFinal Results Year Ended 31 December 2024
16th May 20257:00 amRNS-RPortfolio Company Update - Guident Corp
12th May 20257:00 amRNSPortfolio Company Update:Guident Corp Proposed IPO
6th May 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc.
28th Apr 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc
24th Apr 20257:00 amRNSQ1 2025 Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.